Ratings by Guggenheim
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 7/21/2026 | Kelsey Goodwin | UroGen Pharma | URGN | Maintain | Buy (N/A) |
42.00 (32.00) |
|
Details | |
| 7/21/2026 | Yatin Suneja | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
1,000.00 (995.00) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 6,194 more... | |||||||||
